Loading...
Docoh

Eloxx Pharmaceuticals (ELOX)

782 filings

Newest first
Filter options loading...
Top filers
Top filing types
Recent filing years
8-K
ELOX Eloxx Pharmaceuticals Inc
10 May 22
Eloxx Pharmaceuticals Reports First Quarter 2022 Financial and Operating Results and Provides Business Update
5:28pm
424B5
ELOX Eloxx Pharmaceuticals Inc
6 May 22
Prospectus supplement for primary offering
5:02pm
10-Q
2022 Q1
ELOX Eloxx Pharmaceuticals Inc
6 May 22
Quarterly report
4:19pm
DEFA14A
ELOX Eloxx Pharmaceuticals Inc
29 Apr 22
Additional proxy soliciting materials
4:15pm
DEF 14A
ELOX Eloxx Pharmaceuticals Inc
28 Apr 22
Definitive proxy
8:00pm
8-K
ELOX Eloxx Pharmaceuticals Inc
4 Apr 22
Eloxx Pharmaceuticals Reports Fourth Quarter 2021 Financial and Operating Results and Provides Business Update
8:45am
10-K
2021 FY
ELOX Eloxx Pharmaceuticals Inc
30 Mar 22
Annual report
5:21pm
SC 13G/A
Roche Finance LTD
14 Feb 22
Eloxx Pharmaceuticals / ROCHE FINANCE ownership change
6:18am
SC 13D/A
LSP V Cooperatieve U.A.
3 Feb 22
Eloxx Pharmaceuticals / LSP V Cooperatieve U.A. ownership change
4:16pm
8-K
ELOX Eloxx Pharmaceuticals Inc
4 Jan 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
7:00pm
4
Alan Edmund Walts
3 Dec 21
Eloxx Pharmaceuticals / Alan Edmund Walts ownership change
5:16pm
4
ELOX Eloxx Pharmaceuticals Inc
3 Dec 21
Eloxx Pharmaceuticals / Sumit Aggarwal ownership change
5:15pm
4
Vijay Modur
3 Dec 21
Eloxx Pharmaceuticals / VIJAY MODUR ownership change
5:14pm
4
Geffken Daniel E.
1 Dec 21
Eloxx Pharmaceuticals / Daniel E. Geffken ownership change
11:06am
8-K
ELOX Eloxx Pharmaceuticals Inc
17 Nov 21
Eloxx Pharmaceuticals Reports Positive Topline Results from Monotherapy Arms of Phase 2 Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients
7:41am
8-K
ELOX Eloxx Pharmaceuticals Inc
9 Nov 21
Eloxx Pharmaceuticals Reports Third Quarter 2021 Financial and Operating Results and Provides Business Update
8:03am
10-Q
2021 Q3
ELOX Eloxx Pharmaceuticals Inc
8 Nov 21
Quarterly report
5:30pm
8-K
ELOX Eloxx Pharmaceuticals Inc
5 Oct 21
Entry into a Material Definitive Agreement
8:10am
424B5
ELOX Eloxx Pharmaceuticals Inc
30 Sep 21
Prospectus supplement for primary offering
9:17am
8-K
ELOX Eloxx Pharmaceuticals Inc
30 Sep 21
Entry into a Material Definitive Agreement
8:52am